BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2709320)

  • 21. Kinetics and mechanisms of etodolac degradation in aqueous solutions.
    Lee YJ; Padula J; Lee HK
    J Pharm Sci; 1988 Jan; 77(1):81-6. PubMed ID: 2964523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation kinetics of butylmethoxydibenzoylmethane (avobenzone) in aqueous solution.
    Mbah CJ
    Pharmazie; 2007 Oct; 62(10):747-9. PubMed ID: 18236778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation kinetics and mechanisms of moricizine hydrochloride in acidic medium.
    King SP; Sigvardson KW; Dudzinski J; Torosian G
    J Pharm Sci; 1992 Jun; 81(6):586-91. PubMed ID: 1522500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics and mechanism of degradation of cefotaxime sodium in aqueous solution.
    Berge SM; Henderson NL; Frank MJ
    J Pharm Sci; 1983 Jan; 72(1):59-63. PubMed ID: 6298400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicochemical properties of CWJ-a-5, a new antitumor 3-arylisoquinoline derivative.
    Kim KE; Cho WJ; Kim TS; Kang BH; Chang SJ; Lee CH; Kim DD
    Drug Dev Ind Pharm; 2002 Aug; 28(7):889-95. PubMed ID: 12236074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids.
    Taylor R; Sunderland B; Luna G; Czarniak P
    Drug Des Devel Ther; 2017; 11():2087-2097. PubMed ID: 28744100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of alkali and simulated gastric and intestinal fluids on danazol stability.
    Gadkariem EA; El-Obeid HA; Abounassif MA; Ahmed SM; Ibrahim KE
    J Pharm Biomed Anal; 2003 Mar; 31(4):743-51. PubMed ID: 12644201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoxazoles. 10. Degradation and enolization kinetics of 4-aminoisoxazolyl-1,2-naphthoquinone in basic aqueous solution.
    Ortiz CS; de Bertorello MM
    J Pharm Sci; 1995 Jun; 84(6):783-5. PubMed ID: 7562423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics and mechanism of cymoxanil degradation in buffer solutions.
    Morrica P; Trabue S; Anderson JJ; Lawler S; Seccia S; Fidente P; Swain RS; Mattson SL
    J Agric Food Chem; 2004 Jan; 52(1):99-104. PubMed ID: 14709020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degradation kinetics and mechanism of N6-[(dimethylamino)methylene]mitomycin C in aqueous solutions.
    Chen CM; Coppola WP; Johns WH; Bogardus JB; Lipper RA
    J Pharm Sci; 1986 Feb; 75(2):208-10. PubMed ID: 3958935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation kinetics of the new antibacterial fluoroquinolone derivative, orbifloxacin, in aqueous solution.
    Morimura T; Ohno T; Matsukura H; Nobuhara Y
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1052-4. PubMed ID: 7641305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.
    Parasrampuria J; Gupta VD
    J Pharm Sci; 1989 Oct; 78(10):855-7. PubMed ID: 2600793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solution stability of ciclosidomine.
    Carney CF
    J Pharm Sci; 1987 May; 76(5):393-7. PubMed ID: 3656101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of pH and temperature on the degradation kinetics of 4-methoxy-2-[3-(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c] pyridine in aqueous solutions.
    Muszalska I; WituĊ‚a K
    Acta Pol Pharm; 2005; 62(2):83-8. PubMed ID: 16161346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of lidocaine in aqueous solution: effect of temperature, pH, buffer, and metal ions on amide hydrolysis.
    Powell MF
    Pharm Res; 1987 Feb; 4(1):42-5. PubMed ID: 3508528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabine.
    Kirsch LE; Notari RE
    J Pharm Sci; 1984 Jul; 73(7):896-902. PubMed ID: 6206222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.
    Oliyai C; Borchardt RT
    Pharm Res; 1993 Jan; 10(1):95-102. PubMed ID: 8430066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The aqueous stability of bupropion.
    O'Byrne PM; Williams R; Walsh JJ; Gilmer JF
    J Pharm Biomed Anal; 2010 Nov; 53(3):376-81. PubMed ID: 20547024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine degradation kinetics in aqueous solution.
    Mbah CJ
    Pharmazie; 2011 Mar; 66(3):168-70. PubMed ID: 21553645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin.
    Fabre H; Eddine NH; Berge G
    J Pharm Sci; 1984 May; 73(5):611-8. PubMed ID: 6330342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.